FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst...

https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines-biologics

Vaccine stocks are trading lower Monday following a shakeup at the U.S. Food and Drug Administration.

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Trump's proposed 25% tariffs on auto, semiconductor, and pharmaceutical imports have rattled markets and could affect ETFs ...

Investors may be underestimating Trump's potential push for fiscal discipline, making long-term bonds and rate-sensitive se...

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

The Federal Reserve's final meeting of the year has historically caused significant moves in 20 ETFs. A rate cut is expecte...

To gain an edge, this is what you need to know today.